Cargando…
Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
Vaccines are considered by many to be one of the most successful medical interventions against infectious diseases. But many significant obstacles remain, such as optimizing DNA vaccines for use in humans or large animals. The amount of doses, route and easiness of administration are also important...
Autores principales: | Gonçalves, Eduardo DC, Bonato, Vânia Luiza D, da Fonseca, Denise M, Soares, Edson G, Brandão, Izaíra T, Soares, Ana Paula M, Silva, Célio L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042972/ https://www.ncbi.nlm.nih.gov/pubmed/17714584 http://dx.doi.org/10.1186/1479-0556-5-7 |
Ejemplares similares
-
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
por: Rosada, Rogério S, et al.
Publicado: (2008) -
Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage
por: Pelizon, Ana Cláudia, et al.
Publicado: (2007) -
DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes
por: Santos, Rubens R, et al.
Publicado: (2009) -
BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2013) -
Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65)
por: Silva, Celio Lopes, et al.
Publicado: (2020)